v3.26.1
Share-based payments (Tables)
 6 Months Ended
Jun. 30, 2026
Notes and other explanatory information [abstract]  
Schedule of outstanding options

 

   For the six months ended June 30, 
   2026   2025 
   Number of options  

Weighted average

exercise prices

   Number of options  

Weighted average

exercise prices

 
Outstanding at beginning of the period   1,917,529    89.18    1,287,065    116.33 
Granted during the period   -    -    -    - 
Exercised during the period   -    -    -    - 
Forfeited during the period   (99,142)   71.73    (7,173)   113.06 
Expired   (22,841)   77.55    (303,237)   101.31 
Outstanding at the end of the period   1,795,546    84.63    976,655    121.01 
Exercisable at the end of the period   1,390,379    88.36    903,147    116.80 
Schedule of outstanding warrants

Details of outstanding warrants during the period are presented below:

 

   For the six months ended June 30, 
   2026   2025 
   Number of warrants  

Weighted average

exercise prices

   Number of warrants  

Weighted average

exercise prices

 
Outstanding at beginning of the period   1,561,400    72.84    -    - 
Granted during the period   -    -    -    - 
Exercised during the period   (22,313)   73.05    -    - 
Forfeited during the period   (144,799)   73.05    -    - 
Expired   -    -    -    - 
Outstanding at the end of the period   1,394,288    72.83    -    - 
Exercisable at the end of the period   1,098,598    72.85    -    - 
Schedule of fair market value of the warrants

Details of outstanding warrants during the six months ended June 30, 2026, and 2025 are presented below:

 

       
   For the six months ended June 30, 
   2026   2025 
  

Number of warrants

  

Number of warrants

 
Outstanding at beginning of the period   14,790,570    - 
Granted during the period   -    15,298,552 
Exercised during the period   (12,071,282)   - 
Forfeited during the period   (127,356)   - 
Expired during the period   -    - 
Outstanding at the end of the period   2,591,932    15,298,552 
Schedule of consolidated financial statements of loss

The shared-based payments are presented in following line items in the interim condensed consolidated financial statements of loss:

 

(SEK in thousand)      
   For the six months ended June 30, 
(SEK in thousand)  2026   2025 
Cost of sales   (1,286)   (4)
Selling expenses   (2,390)   (9)
General and administrative expenses   (245,348)   (192)
Research and development expenses   (308)   52 
Total   (249,332)   (152)